NCT02314299View on ClinicalTrials.gov

A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

June 30, 2015

Conditions
Diabetic Macular EdemaAge-related Macular Degeneration
Interventions
DRUG

MTP-131

Trial Locations (1)

Unknown

Boston

All Listed Sponsors
lead

Stealth BioTherapeutics Inc.

INDUSTRY

NCT02314299 - A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration | Biotech Hunter | Biotech Hunter